These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Morice P; Rodriguez A; Rey A; Pautier P; Atallah D; Genestie C; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D Eur J Gynaecol Oncol; 2003; 24(3-4):237-40. PubMed ID: 12807231 [TBL] [Abstract][Full Text] [Related]
17. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease. Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425 [TBL] [Abstract][Full Text] [Related]
18. The role of surgery and treatment trends in uterine sarcoma. Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053 [TBL] [Abstract][Full Text] [Related]
19. Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report. Patsner B; Mann WJ Cancer; 1988 Oct; 62(7):1355-8. PubMed ID: 3166396 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of patients with sarcoma of the uterus]. Bokhman IaV; Urmancheeva AF Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]